Compare Ambarella Inc (AMBA) vs TG Therapeutics Inc (TGTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ambarella Inc vs TG Therapeutics Inc — how do they compare? Ambarella Inc trades at $83.67 (market cap $3.64B), while TG Therapeutics Inc trades at $49.44 (market cap $7.64B). The key difference: TG Therapeutics Inc is far larger — about 2.1× Ambarella Inc's market cap. Which is the better fit depends on your goals.
| AMBA | TGTX | |
|---|---|---|
Market Cap | $3.64B | $7.64B |
Sector | Technology | Health |
52-Week High | $95.51 | $59.06 |
52-Week Low | $48.65 | $26.94 |
Enterprise Value | $3.37B | $7.84B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ambarella (AMBA) trades at $83.48, up 1.76% with a bullish technical signal. Recent earnings beats and a strong analyst consensus support momentum. Revenue growth is projected from $285M in 2025 to $405M in 2026, though net losses persist. News highlights include potential acquisition talks with NXP and optimism around edge AI chips.
Outlook is positive with a $108.67 price target, but risks include sustained losses and competitive pressures. The stock's edge AI focus offers growth potential, yet profitability challenges and market volatility warrant caution for investors.
TG Therapeutics (TGTX) trades at $49.66, up 1.02% on the day, with a bearish technical signal and recent earnings misses despite strong revenue growth. The company reported Q2 2026 revenue of $240 million and raised full-year BRIUMVI guidance to $950 million, but net income was impacted by manufacturing investments. Valuation ratios show a high P/E of 18.22 and EV/EBITDA of 56.26, while profitability metrics like ROE of 100.28% remain robust.
Outlook is mixed: strong product demand and raised revenue targets support growth, but earnings volatility and a bearish technical trend pose risks. Analyst consensus is bullish with an $63.75 price target, though legal investigations and competitive pressures require monitoring for stock investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ambarella Inc
Ambarella is a semiconductor company specializing in low-power video compression and computer vision processors. Its chips power AI cameras for security, automotive safety, and robotics applications.
Read more on AMBA →About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →
